Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1996-1-11
|
pubmed:abstractText |
The point mutation Arg506- > Gln of factor V was recently shown to be an important and relatively common genetic cause of venous thromboembolism. Using a DNA technique based on polymerase chain reaction, we surveyed the blood samples of 236 patients with ischaemic stroke or a transient ischaemic attack, 122 survivors of myocardial infarction and 137 control subjects for the presence of this mutation. Although the frequency of the factor V mutation in patients with arterial disease (4.5%) was not significantly different from that in healthy blood donors (2.9%), a carrier status for this mutant gene was associated with symptoms of migraine and relatively mild angiographic abnormalities among patients with cerebrovascular disease. A more extensive study addressing the occurrence and significance of the mutant factor V mutation in patients with vasospastic cerebrovascular diseases seems to be warranted.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0340-6245
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
558-60
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7495058-Adult,
pubmed-meshheading:7495058-Arginine,
pubmed-meshheading:7495058-Brain Ischemia,
pubmed-meshheading:7495058-Factor V,
pubmed-meshheading:7495058-Female,
pubmed-meshheading:7495058-Finland,
pubmed-meshheading:7495058-Glycine,
pubmed-meshheading:7495058-Humans,
pubmed-meshheading:7495058-Male,
pubmed-meshheading:7495058-Middle Aged,
pubmed-meshheading:7495058-Myocardial Infarction,
pubmed-meshheading:7495058-Point Mutation,
pubmed-meshheading:7495058-Survivors
|
pubmed:year |
1995
|
pubmed:articleTitle |
Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction.
|
pubmed:affiliation |
Second Department of Medicine, University of Helsinki, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|